Defunct Company
Total Trials
22
As Lead Sponsor
12
As Collaborator
10
Total Enrollment
38,142
NCT04364386
Feasibility Clinical Investigation Using the InPress Device for the Treatment of Postpartum Hemorrhage
Phase: N/A
Role: Lead Sponsor
Start: Jul 27, 2014
Completion: Apr 1, 2015
NCT02511301
Circadian Thermal Sensing to Detect Breast Disease
Phase: Phase 1/2
Start: Jun 30, 2015
Completion: Feb 29, 2020
NCT02678611
A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects.
Phase: Phase 1
Start: Jan 31, 2016
Completion: Not specified
NCT03489200
EH301 for the Treatment of ALS
Start: Jan 31, 2017
Completion: Jun 30, 2017
NCT02883673
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
Start: Sep 17, 2017
Completion: Mar 25, 2020
NCT03176628
Pharmacokinetics, Pharmacodynamics and Safety of Basis in Acute Kidney Injury Study
Role: Collaborator
Start: Nov 1, 2017
Completion: Sep 11, 2018
NCT03513523
Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
Start: Apr 18, 2018
Completion: Aug 17, 2020
NCT03635411
Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET)
Start: Dec 6, 2018
Completion: Dec 31, 2020
NCT04220658
Biomarker Study to Evaluate Correlations Between Epigenetic Aging and NAD+ Levels in Healthy Volunteers
Start: Dec 19, 2019
Completion: Dec 3, 2023
NCT04407390
Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly
Phase: Phase 2
Start: Jun 1, 2020
Completion: May 1, 2022
NCT04995887
RUBY Post-Market Registry on the Jada® System
Start: Oct 1, 2020
Completion: Apr 30, 2022
NCT04562831
The NO-ALS Study: a Trial of Nicotinamide/pterostilbene Supplement in ALS.
Start: Oct 7, 2020
Completion: Aug 31, 2025
NCT04342975
Protection From Acute Kidney Injury (AKI) With Basis™ Treatment
Start: Dec 1, 2020
Completion: Mar 14, 2024
NCT04990869
Inflammation in COPD and the Effect of Nicotinamide Riboside
Start: Aug 5, 2021
Completion: Aug 18, 2022
NCT05095571
A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study
Start: Oct 7, 2021
Completion: Dec 31, 2026
NCT05593939
Slow Age: Interventions to Slow Aging in Humans
Start: May 1, 2022
Completion: Dec 21, 2022
NCT04050358
Effect of Basis™ and High Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance
Start: Feb 28, 2023
Completion: May 31, 2023
NCT05760547
The Translational Initiative to Map Epigenetics in Aging (TIME-A)
Start: Mar 8, 2023
Completion: Mar 31, 2033
NCT05483465
The Effect of NAD Supplementation on Brain Vascular Health in Aging
Phase: Phase 4
Start: May 3, 2023
Completion: Dec 31, 2027
NCT06162013
The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism
Start: Mar 5, 2024
Completion: Dec 31, 2028
NCT06333301
Translational Initiative to Map Epigenetics in Sleep
Start: Apr 30, 2024
Completion: Apr 30, 2034
NCT06853743
The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease
Start: Mar 18, 2025
Completion: Mar 31, 2029